Second Foralumab SPMS Patient Continues to Improve & Functional Medicine for MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how six months of treatment with foralumab nasal spray led to significant functional improvements in the second patient with non-active SPMS.
He also reads the latest installment of our “Expert Voices” series, where Dr. Susan Payrovi, MD, answers questions about functional medicine care with MS.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: multiplesclerosisnewstoday.com/forums/